Irinotecan is indicate for the treatment of patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following 5-FU-based therapy.
Sign up for Free to continue reading
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
